Literature DB >> 31839553

Coping with family stress in individuals at clinical high-risk for psychosis.

Claire I Yee1, Tina Gupta2, Vijay A Mittal2, Claudia M Haase3.   

Abstract

BACKGROUND: Despite the long-emphasized role of the family environment in the schizophrenia literature, coping with family stress has been neglected in research on the psychosis risk period.
METHODS: The sample consisted of 75 youth at clinical high-risk (CHR) for psychosis and 79 matched healthy controls who reported on their use of engagement and disengagement coping strategies in response to stress with parents and perceived social support (i.e., advice availability, family support and strain). Participants were also assessed for clinical symptoms.
RESULTS: Individuals at CHR reported similar levels of engagement strategies (e.g., emotion regulation, positive thinking) and more frequent use of disengagement strategies (e.g., avoidance, denial) compared to healthy controls. In individuals at CHR (as well as healthy controls), greater use of engagement strategies predicted greater perceptions of availability of advice support, whereas greater employment of disengagement strategies predicted lower perceived social support from the family and greater family strain. In individuals at CHR (as well as healthy controls), engagement strategies were not linked to any clinical outcomes, whereas disengagement strategies were closely tied to anxiety and depression (but not psychosis symptoms in individuals at CHR).
CONCLUSIONS: Individuals at CHR appeared to engage the same amount as controls, but disengage more often when coping with family stress; this pattern was linked to perceptions of social support and tied to a putative family environment as well as clinical phenomenology. The findings have implications for targeting interventions for CHR populations during a vulnerable period for stress and social change.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Coping; Family; Prodrome; Psychosis; Stress

Mesh:

Year:  2019        PMID: 31839553     DOI: 10.1016/j.schres.2019.11.057

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  7 in total

1.  Association between Parents' Relationship, Emotion-Regulation Strategies, and Psychotic-like Experiences in Adolescents.

Authors:  Chenyu Zhan; Ziyu Mao; Xudong Zhao; Jingyu Shi
Journal:  Children (Basel)       Date:  2022-05-31

2.  The relationship between stress responding in family context and stress sensitivity with sleep dysfunction in individuals at clinical high-risk for psychosis.

Authors:  Ivanka Ristanovic; Claudia M Haase; Jessica R Lunsford-Avery; Vijay A Mittal
Journal:  J Psychiatr Res       Date:  2022-03-02       Impact factor: 5.250

3.  Genuine and non-genuine smiles in individuals meeting criteria for a clinical high-risk syndrome.

Authors:  Jordyn R Ricard; Tina Gupta; Teresa Vargas; Claudia M Haase; Vijay A Mittal
Journal:  Early Interv Psychiatry       Date:  2021-11-01       Impact factor: 2.721

4.  Clues from caregiver emotional language usage highlight the link between putative social environment and the psychosis-risk syndrome.

Authors:  Tina Gupta; William S Horton; Claudia M Haase; Emily E Carol; Vijay A Mittal
Journal:  Schizophr Res       Date:  2022-04-07       Impact factor: 4.662

5.  A Bioecosystem Theory of Negative Symptoms in Schizophrenia.

Authors:  Gregory P Strauss
Journal:  Front Psychiatry       Date:  2021-03-25       Impact factor: 4.157

6.  Perceived Family Functioning Profile in Adolescents at Clinical High Risk for Psychosis: Rigidity as a Possible Preventive Target.

Authors:  Melanie Iorio; Erica Casini; Stefano Damiani; Paolo Fusar-Poli; Renato Borgatti; Martina Maria Mensi
Journal:  Front Psychiatry       Date:  2022-04-15       Impact factor: 5.435

Review 7.  Transcranial direct current stimulation and emotion processing deficits in psychosis and depression.

Authors:  Tina Gupta; Vijay A Mittal
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2020-06-01       Impact factor: 5.270

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.